Responsible Care
27-oct.-2011
After a good third quarter: Bayer Confirms Group Outlook
The Bayer Group achieved further sales growth and significantly increased earnings in the third
quarter of 2011. "It was a good quarter for Bayer," Management Board Chairman Dr. Marijn Dekkers
said Thursday at the presentation of the interim report. He described the continuing growth
momentum in the emerging markets as a key success factor. "Another highlight was the substantial
increase in earnings at Bayer HealthCare and CropScience," Dekkers added. At MaterialScience, on
the other hand, earnings were diminished by higher energy and raw material costs. He also said
Bayer made encouraging progress in research and development, citing positive news from the
late-stage pharmaceutical pipeline. "Based on a good quarter, we can confirm the full-year forecast
for the Bayer Group that we already raised in the spring," said Dekkers.
The full story can
be read here.
After a good third quarter: Bayer Confirms Group Outlook